Consumer protection · from the 250-topic plan
The second opinion: when to leave your GLP-1 program — and how to do it without losing a week
Loyalty to a telehealth program is not a virtue; it's a monthly decision. The leave signals: clinicians you can't reach when it matters, autopilot escalation that ships dose increases nobody discussed, billing that violates what you agreed to, shipping chaos that keeps breaking your dose schedule, or integrity flags that surfaced after signup. The clean exit: request your records (federal law gives you a right of access, generally within 30 days), line up the new program while the old one still ships, cancel per the playbook with timestamps, and carry your dose history forward — because switching programs is not switching medicine: same molecule, same rung, next scheduled dose, no washout, no restart. The only thing you should lose in a program switch is the problem.
The leave signals, ranked
Go now: billing after cancellation or terms nobody agreed to (the ladder handles the money; a new program handles the medicine), any instant-disqualifier flag that surfaced post-signup — salt-form paperwork, an unnameable pharmacy, “FDA-approved” claims on compounded product. Go soon: the unreachable clinical team (the Tuesday-question test failed twice), refills that escalate your dose on autopilot regardless of reported symptoms — a hold request that gets shipped anyway is a program telling you who's driving — and chronic shipping failures that turn your steady state into a sawtooth. Weigh it: price drift above the audited field, service decay, or simply a better-verified option; consumer arithmetic, no drama required.
Your records, your right
Federal privacy law's least-known clause is its most useful: patients hold a right of access to their medical records — programs must provide copies on request, generally within 30 days, at most for a reasonable copying fee. The ask, in writing: “Please provide my complete records — visit notes, prescriptions with doses and dates, and labs — under my HIPAA right of access.” A program that stalls past its deadline or claims your chart is proprietary has committed a violation and a confession in one move; document it, complain (the federal health-privacy portal takes minutes), and proceed — the new program can rebuild essentials from your own history if needed. Records held hostage are a reason you left, not a reason you can't.
Medical continuity: the part that's actually easy
The pharmacology doesn't care which website bills you: same molecule, same dose, next scheduled injection — a program switch done on schedule is invisible to your bloodstream. What the new program needs: current molecule and rung, time at that rung, tolerability notes, and any relevant history — the same handoff document a molecule switch would use, minus the molecule part. Expect a real intake (a legitimate evaluation is a feature, not friction) and a prescriber who confirms rather than rubber-stamps your dose; both are the point of leaving somewhere worse.
The exit sequence, ordered
One: request records (start the 30-day clock early). Two: enroll and complete intake at the verified new program — the walkthrough and the manual are the vetting so this article never applies twice. Three: time the seam: confirm the new program's first shipment date against your remaining supply so dose day never lacks a dose. Four: cancel the old program in writing per its terms and your state's rules, timestamps kept, confirmation demanded. Five: watch the card for a statement cycle — the ladder exists if the exit gets billed. Total effort: an evening; total medical disruption when sequenced: none.
The two traps
Sunk cost: prepaid months at a failing program are the refund taxonomy's problem, not a reason to keep injecting under bad care — run the effective-price math, pursue what's recoverable, and let the rest buy the lesson. The gap drift: “I'll cancel first, then find somewhere” turns a program switch into an unplanned off-ramp — weeks slip, levels fall, the regain clock starts, and restarting means re-titration. New program first, then cancel; the order is the whole trick. And the standing benchmark for what “worth staying” looks like: published terms, reachable clinicians, dose-proof billing, and a 30-day written exit — the audited configuration this database scores everything against. The configuration worth staying for ↗
FAQ
Can I switch GLP-1 programs without stopping my medication?
Yes — same molecule, same dose, next scheduled injection; sequence the new program's first shipment against your remaining supply and the switch is invisible to your bloodstream.
Can my telehealth program refuse to give me my records?
No — federal law grants a right of access, generally within 30 days for at most a reasonable fee; stalling is a violation you can report while proceeding with your history.
What are the clearest signs to leave a GLP-1 program?
Billing violations, autopilot dose escalation over your objections, unreachable clinicians, chronic shipping failures, or integrity flags surfacing after signup.
Should I cancel before or after joining a new program?
After — enroll, confirm the first shipment date, then cancel in writing; the reverse order creates a medication gap that starts the regain clock.
Sources
- HIPAA right-of-access provisions and complaint process.
- State ARL cancellation rules; chargeback frameworks — companion analyses.
- Pharmacokinetic continuity — the half-life file; program-vetting instruments on this site.